Company file · THC
Tenet Health
Tenet Health's revenue rose 3.1% in FY2025, to $21.3B, and net income fell 41.8% to $2.4B
Revenue rose 3.1% to $21.3B in FY2025, from $20.7B in FY2024. Net income fell 41.8% to $2.4B. Hospital Operations was the largest segment, at 76% of revenue.
Key facts
In fiscal 2025, which ended Dec 31, 2025, Tenet Health (NYSE: THC) took in $21.3B of revenue (up 3.1% on fiscal 2024); net income was $2.4B (down 41.8%). The most recent quarter, ended Sep 30, 2026, brought revenue of $5.6B, up 6.5% year over year, with net income of $1.2B. Hospital Operations was the biggest single line by segment: 76% of fiscal 2025 revenue. Sources: 10-K for fiscal 2025 (filed Feb 17, 2026) and 10-Q for the quarter ended Sep 30, 2026 (filed Oct 29, 2026).
Source: 10-K FY2025, filed Feb 17, 2026
Source: 10-Q filed Apr 30, 2026 · 10-Q filed Jul 29, 2026 · 10-Q filed Oct 29, 2026
How it makes money
By segment, FY2025
Source: 10-K FY2025, XBRL breakdown
By segment in FY2025: Hospital Operations (76%) and Ambulatory Care (24%), as shares of total revenue. Total revenue was $21.3B.
Source: 10-K FY2025
Learn more: Revenue vs. net income · Gross, operating and net margin
What changed last quarter
Comparing Q3 2026 (Jul to Sep 2026) compared with Q3 2025 (Jul to Sep 2025)
Each pair of bars shows the dollar amount for both quarters. Longer bar, more money. Bars in a group share one scale.
Q3 2026Q3 2025
Company
Source: Tenet Health 10-Q for the quarter ended Sep 30, 2026, filed Oct 29, 2026
By segment
Source: Tenet Health 10-Q for the quarter ended Sep 30, 2026, filed Oct 29, 2026
The bull case and the bear case
The bull case
- Revenue rose 3.1% in FY2025 to $21.3B, from $20.7B a year earlier. 10-K, FY2025
- Operating cash flow rose 72.9% in FY2025 to $3.5B. 10-K, FY2025
- Diluted shares fell 7.2% in FY2025, so each share represents a larger slice of profit. 10-K, FY2025
- Revenue in the quarter ended Sep 30, 2026 was $5.6B, up 6.5% on a year earlier. 10-Q, quarter ended Sep 30, 2026
The bear case
- Net income fell 41.8% in FY2025 to $2.4B, from $4.1B. 10-K, FY2025
- Hospital Operations revenue fell 0.0% in FY2025 to $16.1B. 10-K, FY2025
- The company's own risk factors are in Item 1A of its 10-K. Risks common in this industry include regulation; pricing and reimbursement; competition. 10-K, Item 1A
What optimists and skeptics tend to point to, each tied to a filing. Ticker Sage doesn't pick a side, and neither list is a reason to buy or sell.
What the company does
Tenet Health is in the health care facilities industry, part of the health care sector. The SEC files it under Services-General Medical & Surgical Hospitals, Nec.
Tenet Health reports 2 segments: Hospital Operations and Ambulatory Care.
Its fiscal year ends in December; the latest, FY2025, ended Dec 31, 2025.
Source: 10-K, Item 1 Business
Risks common in this industry
These are general risks for companies in the health care facilities industry. They are not a summary of Tenet Health’s own risk factors; for those, read Item 1A of its latest 10-K, linked below.
- RegulationApprovals, safety rules and government oversight shape what it can sell and how.
- Pricing and reimbursementPayers, insurers and governments influence what it can charge.
- CompetitionNew treatments, generics and rival products can take share.
- LitigationProduct liability and other legal claims can lead to costs.
- SupplyManufacturing and supplier problems can interrupt products.
Source: 10-K, Item 1A Risk Factors (the company's own list, in the company's words)
Three years of key numbers
Every number links to its filing; hover for the XBRL tag. A dash means the number isn't cleanly available, and we don't estimate it.
| US$ | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | $20.6B | $20.7B | $21.3B |
| Net income | $1.3B | $4.1B | $2.4B |
| Operating cash flow | $2.4B | $2.0B | $3.5B |
| Cash & equivalents (year end) | $1.2B | $3.0B | $2.9B |
| Total debt (year end) | $15.0B | $13.2B | $13.2B |
| Diluted shares | 105M | 98M | 91M |
- Revenue: Total revenue for the fiscal year, as the company reports it on its income statement.
- Net income: Net income including the share that belongs to minority owners of subsidiaries.
- Operating cash flow: Cash the business brought in from its day-to-day operations during the year (cash flow statement).
- Cash & equivalents: Cash and short-term investments that count as cash equivalents on the balance sheet. Excludes longer-dated marketable securities.
- Total debt: Debt and finance lease obligations, including the part due within one year, at carrying value, as the company totals it.
- Diluted shares: Weighted average shares outstanding for the year, including the effect of options and stock awards.
Learn more: How to read an income statement · Earnings per share, basic and diluted · Free cash flow · How to read a balance sheet · Growth rate calculator · P/E calculator · Market cap calculator · Free cash flow calculator · Return on equity and assets calculator
Explainers for this page
- Segment reporting
- Net debt and net cash
- Debt-to-equity ratio
- The cash flow statement
- Risk factors (Item 1A)
- Book value per share
- Rule 10b5-1 trading plans
Guides to terms this file uses, with real numbers from filings.
About these numbers
- Net income here includes the share that belongs to minority owners of subsidiaries, the figure the company's tagged data carries for the whole business.
Recent filings
| Form | Filed | Period |
|---|---|---|
| 10-Q | Oct 29, 2026 | Sep 30, 2026 |
| 10-Q | Jul 29, 2026 | Jun 30, 2026 |
| 10-Q | Apr 30, 2026 | Mar 31, 2026 |
| DEF 14A | Apr 16, 2026 | May 27, 2026 |
| 10-K | Feb 17, 2026 | Dec 31, 2025 |
What's in this filing
The quotes below come from Item 1 (Business) of the Form 10-K Tenet Health filed on Feb 17, 2026, its annual report for the fiscal year ended Dec 31, 2025.
The latest quarterly report in the table above is the Form 10-Q filed Oct 29, 2026 for the quarter ended Sep 30, 2026.
A 10-K has audited annual financial statements and the company's own description of its business and risks; a 10-Q has unaudited quarterly statements.
Tenet Healthcare Corporation (“Tenet”) is a diversified healthcare services company with its headquarters in Dallas, Texas, and a Global Business Center (“GBC”) in the Philippines that supports various enterprise-wide administrative functions.
Our business is organized into two separate reporting segments – Hospital Operations and Services (“Hospital Operations”) and Ambulatory Care.
Short excerpts quoted from the filing. The full document is on SEC.gov.
Learn more: 10-K vs. 10-Q vs. 8-K · Form 4 insider filings · Fiscal years and quarters
Common questions about Tenet Health
How does Tenet Health make money?
In fiscal 2025, revenue totaled $21.3B. By segment in FY2025: Hospital Operations (76%) and Ambulatory Care (24%), as shares of total revenue. Total revenue was $21.3B. Source: 10-K for fiscal 2025, filed Feb 17, 2026.
What was Tenet Health's revenue in fiscal 2025?
Revenue came to $21.3B in the year ended Dec 31, 2025. Going back two years, it was $20.6B in fiscal 2023 and $20.7B in fiscal 2024, so the latest year was up 3.1%. Source: 10-K for fiscal 2025, filed Feb 17, 2026.
Is Tenet Health profitable?
Yes, by US accounting rules (GAAP): net income was $2.4B in fiscal 2025, down 41.8% from $4.1B a year earlier. For the quarter ended Sep 30, 2026, net income was $1.2B. The page's About these numbers section explains what is included. Source: 10-K for fiscal 2025, filed Feb 17, 2026.
What did Tenet Health report in its latest quarterly filing?
The 10-Q for the quarter ended Sep 30, 2026 shows revenue of $5.6B, against $5.3B in the same quarter a year before (up 6.5%), and net income of $1.2B, against $579M (up 110.5%). Source: 10-Q for the quarter ended Sep 30, 2026, filed Oct 29, 2026.
How much cash and debt does Tenet Health have?
On Sep 30, 2026, cash and cash equivalents stood at $2.7B and total debt at $13.2B. Total debt here is debt and finance lease obligations, including the part due within one year, at carrying value, as the company totals it. Source: 10-Q filed Oct 29, 2026.
What are the main risks Tenet Health faces?
Tenet Health's own risk factors are in Item 1A of its 10-K for fiscal 2025, filed Feb 17, 2026. Risks that are common among companies in the health care facilities industry include Regulation; pricing and reimbursement; competition; litigation; supply. The first: Approvals, safety rules and government oversight shape what it can sell and how. Source: 10-K, Item 1A Risk Factors.
Where do these Tenet Health numbers come from?
Two filings Tenet Health made with the SEC: its fiscal 2025 10-K, filed Feb 17, 2026, and its 10-Q for the quarter ended Sep 30, 2026, filed Oct 29, 2026. The figures are taken from the XBRL data the SEC publishes, and every one links back to its source. Methodology explains how fiscal years and missing numbers are handled.
Tracked funds that report owning Tenet Health
- Citadel Advisors: 1,765,596 shares, reported value $330.3M at Jun 30, 2026 (+321.6% in shares since the filing for Mar 31, 2026). Form 13F filed Sep 2, 2026.
- Two Sigma Investments: 457,944 shares, reported value $117.0M at Sep 30, 2026 (+1,059.4% in shares since the filing for Jun 30, 2026). Form 13F filed Nov 16, 2026.
- Millennium Management: 412,523 shares, reported value $105.4M at Sep 30, 2026 (new in this filing). Form 13F filed Nov 16, 2026.
- Bridgewater Associates: 106,922 shares, reported value $27.3M at Sep 30, 2026 (+152.3% in shares since the filing for Jun 30, 2026). Form 13F filed Nov 16, 2026.
- Point72 Asset Management: 31,323 shares, reported value $8.0M at Sep 30, 2026 (−83.2% in shares since the filing for Jun 30, 2026). Form 13F filed Nov 16, 2026.
- Maverick Capital: 2,133 shares, reported value $0.5M at Sep 30, 2026 (new in this filing). Form 13F filed Nov 16, 2026.
From each fund’s latest Form 13F, which is filed up to 45 days after quarter end and lists long positions in US-listed stocks only. A listing here is a fact about a filing, not a view on the stock. What a 13F does and doesn’t show.
Disclosures
- Editor holdings in THC
- The editor holds no position in Tenet Health (THC). As of Nov 11, 2026.
- Trading rule
- The editor does not buy or sell THC from 3 days before to 3 days after this page is published or substantively updated.
- Compensation
- Nobody paid for this page. No affiliate links on this page.
- Sources
- The company's SEC filings, linked next to each number or, for charts, in the source line under them.
- Last updated
- Nov 19, 2026
General education, the same for every reader. Not a recommendation to buy, sell or hold THC, and it doesn't consider your situation.
Compare with peers
| Company | Fiscal year | Revenue | Revenue growth | Net income |
|---|---|---|---|---|
| Tenet HealthTHC | FY2025 | $21.3B | +3.1% | $2.4B |
| HCA HealthcareHCA | FY2025 | $75.6B | +7.1% | $6.8B |
| Universal Health ServicesUHS | FY2025 | $17.4B | +9.7% | $1.5B |
| Eli LillyLLY | FY2025 | $65.2B | +44.7% | $20.6B |
Each row is that company’s latest fiscal year from its own 10-K, using its own revenue and net income lines. Fiscal years end in different months, and line definitions differ (banks, insurers and oil companies count revenue differently), so this is a rough side-by-side, not a like-for-like comparison.
More company files
- JNJ Johnson & Johnson
- ABBV AbbVie
- MRK Merck
- TMO Thermo Fisher
- AMGN Amgen
- GILD Gilead
- PFE Pfizer
- DHR Danaher
- BMY Bristol Myers Squibb
- VRTX Vertex Pharmaceuticals
- REGN Regeneron Pharmaceuticals
- MRNA Moderna
- VEEV Veeva Systems
- A Agilent Technologies
- WAT Waters
- IQV IQVIA
- ILMN Illumina
- BIIB Biogen
- MTD Mettler Toledo
- ZTS Zoetis
- INCY Incyte
- VTRS Viatris
- CRL Charles River Laboratories
- SOLV Solventum
- TECH Bio-Techne
- UTHR United Therapeutics
- ALNY Alnylam
- MEDP Medpace
- AAPL Apple
- MSFT Microsoft
New to filings? Learn has explainers built on real filings and Tools has calculators. Methodology & Disclosures covers where every number comes from.